These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30067725)

  • 1. Prediction of Molecular Signature, Potential Biomarkers, and Molecular Pathways Associated with Membranous Nephropathy Based on Protein Protein Interactions.
    Taherkhani A; Kalantari S; Nafar M
    Rev Invest Clin; 2018; 70(4):184-191. PubMed ID: 30067725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic Analysis Reveals Novel Immune-Associated Hub Genes in Human Membranous Nephropathy.
    Tang W; Wang Z; Cao Y; Zhang D; Mi X
    Genet Test Mol Biomarkers; 2019 Jan; 23(1):23-31. PubMed ID: 30526079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes and their correlation with immune infiltrating cells in membranous nephropathy: an integrated bioinformatics analysis.
    Han M; Wang Y; Huang X; Li P; Liang X; Wang R; Bao K
    Eur J Med Res; 2023 Nov; 28(1):525. PubMed ID: 37974210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker prediction for membranous nephropathy prognosis by microarray analysis.
    Zhou G; Xin G; Zhang W; Zhang X
    Nephrology (Carlton); 2019 May; 24(5):526-533. PubMed ID: 30084529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation.
    Zhang P; Geng Y; Tang J; Cao Z; Xiang X; Yang K; Chen H
    Front Immunol; 2023; 14():1252347. PubMed ID: 37876929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of biomarkers in membranous nephropathy and pan-cancer analysis.
    Yang Y; Zou GM; Wei XS; Zhang Z; Zhuo L; Xu QQ; Li WG
    Front Immunol; 2024; 15():1302909. PubMed ID: 38846934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Label-free quantitative proteomic and phosphoproteomic analyses of renal biopsy tissues in membranous nephropathy.
    Li S; Luo Z; Meng S; Qiu X; Zheng F; Dai W; Zhang X; Sui W; Yan Q; Tang D; Dai Y
    Proteomics Clin Appl; 2022 Jan; 16(1):e2000069. PubMed ID: 34543527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of critical genes in nucleus pulposus cells isolated from degenerated intervertebral discs using bioinformatics analysis.
    Zhu Z; Chen G; Jiao W; Wang D; Cao Y; Zhang Q; Wang J
    Mol Med Rep; 2017 Jul; 16(1):553-564. PubMed ID: 28586059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive identification of immune-associated biomarkers based on network and mRNA expression patterns in membranous glomerulonephritis.
    Zhang C; Leng L; Zhang X; Zhao Y; Li Z
    J Transl Med; 2018 Jul; 16(1):210. PubMed ID: 30041664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.
    Kuang Z; Guo L; Li X
    Mol Med Rep; 2017 Oct; 16(4):4685-4693. PubMed ID: 28791394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network analysis of membranous glomerulonephritis based on metabolomics data.
    Taherkhani A; Kalantari S; Arefi Oskouie A; Nafar M; Taghizadeh M; Tabar K
    Mol Med Rep; 2018 Nov; 18(5):4197-4212. PubMed ID: 30221719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common molecular and pathophysiological underpinnings of delirium and Alzheimer's disease: molecular signatures and therapeutic indications.
    Mosharaf MP; Alam K; Gow J; Mahumud RA; Mollah MNH
    BMC Geriatr; 2024 Aug; 24(1):716. PubMed ID: 39210294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway deviation-based biomarker and multi-effect target identification in asbestos-related squamous cell carcinoma of the lung.
    Du J; Zhang L
    Int J Mol Med; 2017 Mar; 39(3):579-586. PubMed ID: 28204826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.